4-OH-E1 Test

Your body does not just make estrogen and use it. It also breaks estrogen down through several different routes, and the route it favors matters for long-term health. One of those routes produces 4-OH-E1 (4-hydroxyestrone), a chemically reactive byproduct that, if not quickly inactivated, can attach to DNA and cause damage.

Knowing your 4-OH-E1 level offers an exploratory window into how your body processes estrogen at the metabolite level, something total estrogen tests cannot show. This is a research-stage marker, so a single number is best understood as one piece of a broader estrogen metabolism picture rather than a stand-alone risk score.

What This Metabolite Reflects

4-OH-E1 is what scientists call a catechol estrogen. It is formed when liver and tissue enzymes attach a chemical group to estrone at a specific spot on the molecule. The same enzymes can also send estrogen down a less reactive path that produces 2-hydroxyestrone (2-OH-E1). Whether your body favors the 4-OH route or the 2-OH route shapes how harsh or gentle your estrogen metabolism is.

After 4-OH-E1 is formed, a follow-up step called methylation converts it into a much safer compound (2-methoxyestrone or 4-methoxyestrone). If methylation is slow or overwhelmed, 4-OH-E1 can be converted instead into reactive forms (called quinones) that bind directly to DNA. This is why the 4-OH-E1 number is most informative when read alongside the methylation step that follows it.

Breast Cancer Associations

In breast tissue studies, tumors contained more 2- and 4-hydroxyestradiol than surrounding normal tissue, and the pattern of hydroxylated estrogens differed between cancerous and healthy samples. In urine samples from postmenopausal women, breast cancer cases showed higher 2- and 4-hydroxyestradiol and lower 2-methoxyestradiol than controls, suggesting that the combination of high 4-OH formation and inadequate methylation may matter more than total estrogen alone.

These findings come from research that measured 4-hydroxyestradiol (a closely related molecule), not 4-OH-E1 in dried urine specifically. The 4-OH route as a whole has been linked to potentially DNA-damaging metabolism, but the exact contribution of urinary 4-OH-E1 to breast cancer risk is still being defined and lacks the long-term outcome data that established markers like LDL cholesterol have.

Endometriosis and Endometrial Tissue

Women with endometriosis showed higher 4-OH-E1 and 4-OH-E2 in the lining of the uterus than women without the disease, in a study of 114 participants. The authors proposed that local estrogen metabolism in endometriosis is shifted toward biologically active and potentially genotoxic metabolites, which may help explain why the tissue persists and grows in places it should not.

This evidence comes from biopsied tissue rather than urine. Whether urinary 4-OH-E1 reflects endometrial 4-OH-E1 in a clinically actionable way has not been directly established, so this finding is best treated as biological context rather than a diagnostic claim.

Reference Ranges

There are no universally accepted clinical cutpoints for 4-OH-E1 in dried urine. Available reference values come from individual labs and research cohorts using mass spectrometry methods, and they vary by menopausal status, cycle phase, and assay. The most useful framing is to view your number alongside the rest of your estrogen metabolite panel rather than against a fixed threshold.

• Absolute level of 4-OH-E1: what your body is producing through the 4-OH pathway
• Ratio of 4-OH to 2-OH: how much of your estrogen is going down the reactive route versus the less reactive one
• Methylation ratio (2-methoxy/2-OH and 4-methoxy/4-OH): how well your body is clearing reactive metabolites once they form

Because cutpoints are not standardized, the most reliable approach is to use the same lab over time and watch your own trend rather than chasing a published number.

When Results Can Be Misleading

• Menstrual cycle timing: estrogen metabolite levels rise and fall through the cycle, so a luteal-phase sample will look different from a follicular one. For premenopausal women, sampling around day 19 to 22 of the cycle is the convention used in most research.
• Smoking and recent smoking history: smoking shifts estrogen metabolism toward both 2- and 4-hydroxylation. A current smoker's 4-OH-E1 result may not reflect their underlying biology if they quit.
• Acute strenuous exercise: a single heavy workout in the day or two before collection has been shown to acutely raise total 4-hydroxyestrogens. Standardize your activity in the 24 to 48 hours before collecting.
• Collection errors: dried urine spots collected at the wrong time of day, with too little volume, or after the sample has been contaminated can produce misleading numbers. Follow the kit instructions exactly.

Tracking Your Trend

Because there are no validated clinical thresholds, the trend matters more than any single value. A baseline reading tells you where you start. A follow-up reading after 3 to 6 months of any intervention tells you whether the change is working. After that, retesting at least once a year gives you a moving picture of how your estrogen metabolism is evolving with age, body composition, and habits.

Use the same lab and the same collection protocol each time. Different assays produce different absolute numbers, so within-lab comparison is the only fair comparison.

If Your Result Is High

A high 4-OH-E1 reading alone is not a diagnosis. The pattern to investigate is high 4-OH-E1 combined with low methylation downstream (a low 4-methoxy-E1 to 4-OH-E1 ratio). That combination suggests your body is producing the reactive metabolite faster than it can clear it. In that case, the next steps are to look at the rest of your estrogen metabolite panel, evaluate liver function and methylation cofactor status (B vitamins, magnesium), and consider speaking with a clinician familiar with hormone metabolism, such as an endocrinologist or a gynecologist with hormone training. For women with a family history of breast cancer or known endometriosis, bringing this pattern to a specialist's attention is reasonable. For everyone else, it is a piece of data to track over time rather than a reason for alarm.